Monoclonal antibody therapy for COVID-19 during pregnancy
Aim. Pregnancy worsens COVID-19 and has been listed by the US Food and Drug Administration as a high risk factor for complicating COVID-19. The severe course of a new coronavirus infection in some pregnant patients has created the prerequisites for the search for treatment methods that can reduce th...
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | Russian |
| Julkaistu: |
ZAO "Consilium Medicum"
2023-09-01
|
| Sarja: | Consilium Medicum |
| Aiheet: | |
| Linkit: | https://consilium.orscience.ru/2075-1753/article/viewFile/609534/138174 |